Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Heptinstall

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Expert Review of Clinical Pharmacology|June 16, 2012
Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromesYanushi Dullewe Wijeyeratne, Rashi Joshi, Stan Heptinstall
Platelets|October 23, 2009
Call for contributions to the new Methods section in PlateletsKen J Clemetson, Paul Harrison, Stan Heptinstall
Platelets|April 19, 2018
Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disordersPhilip M Bath, Jane May, Stan Heptinstall
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Triple antiplatelet therapy for secondary prevention of recurrent ischemic strokeMark Willmot, Lian Zhao, Stan Heptinstall, et al.
Platelets|December 19, 2002
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseaseRobert F Storey, Robert G Wilcox, Stan Heptinstall
Thrombosis and Haemostasis|October 7, 2004
Platelet-monocyte interaction and GPIIb/IIIa blockadeLian Zhao, Philip Bath, Wolfgang Lösche, et al.
Thrombosis Research|January 26, 2005
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirinRobert F Storey, Jane A May, Stan Heptinstall
Platelets|March 23, 2012
PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptorsJacqueline R Glenn, Ann E White, David Iyu, et al.
Thrombosis and Haemostasis|January 17, 2003
Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62PThomas Scholz, Uta Temmler, Siegfried Krause, et al.
Journal of Cardiovascular Pharmacology|June 24, 2006
Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adultsStan Heptinstall, Jane May, Sue Fox, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Expert Review of Clinical Pharmacology|June 16, 2012
Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromesYanushi Dullewe Wijeyeratne, Rashi Joshi, Stan Heptinstall
Platelets|October 23, 2009
Call for contributions to the new Methods section in PlateletsKen J Clemetson, Paul Harrison, Stan Heptinstall
Platelets|April 19, 2018
Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disordersPhilip M Bath, Jane May, Stan Heptinstall
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Triple antiplatelet therapy for secondary prevention of recurrent ischemic strokeMark Willmot, Lian Zhao, Stan Heptinstall, et al.
Platelets|December 19, 2002
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart diseaseRobert F Storey, Robert G Wilcox, Stan Heptinstall
Thrombosis and Haemostasis|October 7, 2004
Platelet-monocyte interaction and GPIIb/IIIa blockadeLian Zhao, Philip Bath, Wolfgang Lösche, et al.
Thrombosis Research|January 26, 2005
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirinRobert F Storey, Jane A May, Stan Heptinstall
Platelets|March 23, 2012
PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptorsJacqueline R Glenn, Ann E White, David Iyu, et al.
Thrombosis and Haemostasis|January 17, 2003
Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62PThomas Scholz, Uta Temmler, Siegfried Krause, et al.
Journal of Cardiovascular Pharmacology|June 24, 2006
Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adultsStan Heptinstall, Jane May, Sue Fox, et al.
Pageof 6